Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glutamic--pyruvic transaminase | 0.403 | 0.923 | 3.6E-19 |
|
disease | 0.100 | None | 0.974 | 76 | 0 | 2001 | 2020 | ||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.100 | None | 0.933 | 45 | 0 | 2003 | 2019 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.100 | None | 0.933 | 45 | 0 | 2003 | 2019 | |||||||||
|
progestagen associated endometrial protein | 0.430 | 0.846 | 3.1E-08 |
|
disease | 0.100 | None | 0.964 | 28 | 0 | 2007 | 2019 | ||||||||
|
fibrillarin | 0.572 | 0.654 | 0.99 |
|
disease | 0.100 | None | 0.950 | 20 | 0 | 2015 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.100 | None | 1.000 | 19 | 0 | 1996 | 2019 | ||||||||
|
tripartite motif containing 21 | 0.485 | 0.808 | 3.4E-09 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 1997 | 2019 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 2014 | 2019 | ||||||||
|
interferon lambda 3 | 0.506 | 0.808 | 2.4E-08 |
|
disease | 0.100 | None | 1.000 | 12 | 1 | 2013 | 2019 | ||||||||
|
tRNA | 0.534 | 0.731 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
ATP synthase F0 subunit 8 | 0.666 | 0.615 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
TTN antisense RNA 1 | 0.599 | 0.577 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
titin | 0.470 | 0.885 | 2.6E-96 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ribonucleotide reductase regulatory TP53 inducible subunit M2B | 0.527 | 0.769 | 2.4E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
microRNA 122 | 0.468 | 0.808 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2011 | 2019 | |||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.090 | None | 0.889 | 9 | 3 | 2011 | 2018 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2001 | 2017 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1997 | 2018 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1998 | 2018 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2007 | 2017 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.080 | None | 1.000 | 8 | 1 | 2010 | 2019 | ||||||||
|
interferon stimulated exonuclease gene 20 | 0.414 | 0.846 | 2.9E-03 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2006 | 2016 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2006 | 2016 | ||||||||
|
toll like receptor 3 | 0.427 | 0.885 | 1.6E-07 |
|
disease | 0.080 | None | 1.000 | 8 | 2 | 2010 | 2019 |